Clinical Trial

Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica

Study acronym: ITTGPMR
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This will be efficacy and safety of Induction and Tapering Therapy with Tofacitinib and Glucocorticoid in patients with Polymyalgia Rheumatica (ITTG PMR): An open-label 52-week randomized controlled trial
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-12-07; most recent amendment 2025-08-11.
Status change: Not Yet Recruiting → Recruiting 2024-07-25
Trial Details
NCT Number NCT06172361
Lead Sponsor Zhejiang University
Conditions Polymyalgia Rheumatica
Enrollment 98 participants
Start Date 2024-01-20
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-13